Impact of a nutritional education program on quality of life, nutritional status and functionality in patients with advanced chronic kidney disease: Ercanut trial

Rationale: Chronic kidney disease (CKD) is a complex condition that requires careful management of diet with many restrictions to slow disease progression while maintaining the individual's overall health status. Methods: Randomized clinical trial comparing the effects of a nutritional educational program (NEP; general dietary recommendations in CKD + proposed diets + nutritional coaching workshops; study group) with that of regular clinical practice (general dietary recommendations in CKD; control group) on quality of life (QoL), nutritional status and functionality in adult patients with advanced CKD (glomerular filtration rate <30ml/min/1.73m2). Baseline and 3-month data were collected: QoL (KDQOLTM-36), nutritional status (anthropometry and bioimpedance) and functionality (dynamometry, SPPB). Results:Tabled 1Control group (n=34)NEP study group (n=33)Baseline3mBaseline3mQoLSymptomatology80.1±16.678.6±19.973.6±19.777.8±19.5Effect of disease81.1±17.875.3±20.269.6±19.076.2±20.1Disease Burden64.0±27.952.6±29.749.4±22.058.0±27.2Physical dimension43.1±9.943.1±10.440.1±9.943.8±10.5Mental dimension45.4±14.148.2±12.144.5±9.848.6±11.2Nutritional statusWeight (kg)78.7±17.276.6±16.881.8±15.579.5±15.2BMI (Kg/m2)28.5±5.026.9±6.528.6±4.427.9±4.3Waist circumference (cm)96.8±14.494.9±13.598.5±13.396.1±12.7Triceps fold (mm)15.9±8.015.0±7.917.2±9.817.2±9.8Fat mass (kg)28.5±5.026.9±6.526.5±8.524.6±8.1Lean mass (kg)53.7±11.452.9±11.255.2±12.354.8±12.0Reactance (Ohm)51.7±14.047.8±14.053.3±14.850.1±11.4Resistance (Ohm)524.8±83.8519.4±82.9542.1±113.7545.4±110.0Phase angle (º)5.6±1.25.2±1.15.6±1.15.3±1.0FunctionalityDynamometry29.9±9.230.0±9.332.4±13.133.0±12.7SPPB10.2±3.210.5±3.09.9±2.810.7±2.2Significant changes (p<.05): Bold Open table in a new tab Significant changes (p<.05): Bold Conclusion: The NEP could be useful to improve QoL, nutritional status and functionality in people with advanced CKD. Disclosure of Interest: None declared